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ABSTRACT
Background. The relationship of kidney size to ageing, kidney
function and kidney disease risk factors is not fully understood.
Methods. Ultrasound length and parenchymal kidney volume
were determined from a population-based sample of 3972
Sardinians (age range 18–100 years). We then identiﬁed the
subset of 2256 ‘healthy’ subjects to deﬁne age- and sex-speciﬁc
reference ranges (2.5–97.5 percentile) of kidney volume.
Logistic regression (accounting for family clustering) was used
to identify the clinical characteristics associated with abnor-
mally large kidneys or abnormally small kidneys.
Results. In the healthy subset, kidney volume and length
increased up to the fourth to ﬁfth decade of life followed by a
progressive decrease in men, whereas there was a gradual kidney
volume decrease throughout the lifespan of women. In the whole
sample, independent predictors of lower kidney volume (<2.5
percentile for age and sex) were male sex, low body mass index,
short height, low waist:hip ratio and high serum creatinine (SCr);
the independent predictors of larger kidney volume (>97.5 per-
centile for age and sex) were younger age, female sex, diabetes,
obesity, high height, high waist:hip ratio and lower SCr.
Estimated heritability for kidney volume was 15%, and for length
27%; kidney volume correlated strongly with birthweight.
Conclusions. Overall, in a general healthy population, kidney
measures declined with age differently in men and women. The
determinants of kidney parenchymal volume include genetic
factors and modiﬁable clinical factors.
Keywords: age, elderly, epidemiology, gender, ultrasonography
INTRODUCTION
Renal function is known to decrease progressively with age even
in healthy individuals, a process called nephrosenescence [1, 2].
Correspondingly, the increased rates of chronic kidney disease
(CKD) observed in the elderly result from ageing-related
decreases in function and from the increasing frequency of risk
factors such as atherosclerosis or diabetes [3, 4]. As apparent indi-
cators of nephrosenescence, imaging findings routinely show re-
nal atrophy and reduced kidney size in patients with CKD,
particularly at advanced stages [5]. Previous work also suggested
an age-related loss of total or parenchymal kidney volume (PKV)
in normal subjects, and it has even been suggested that in healthy
kidney donors kidney volume could be a surrogate for kidney
function [6, 7]. The relationship between renal volume and func-
tion during ageing remains unclear [8] and not always propor-
tional, because the kidney has a considerable functional reserve
and homeostatic adaptive mechanisms [9]. For example, glomer-
ular filtration rate (GFR) can be sustained within the normal
range in kidney donors even after the loss of functional paren-
chyma [10] and can be increased as required in pregnancy [11]
or after partial or radical nephrectomy in adults [12].
Furthermore, complicating inferred links between kidney
volume and function during ageing, there may be possible
differential effects in men and women [7]. Other relevant
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ageing-related factors include the increase of renal sinus fat, pa-
renchymal cysts [13] and CKD risk factors such as diabetes and
obesity [14]. Different ethnicity and a limited number of ob-
served aged individuals may constitute additional limits [15–17].
Here we aimed to extend previous analyses about the age-
ing-dependent decline of estimated GFR (eGFR) [1] in a large
cohort of Sardinians, including substantial numbers of individ-
uals >70 years of age. In this cross-sectional study we further
analysed the relationship of PKV and length with age, renal
function, CKD risk factors, birthweight (BW) and heritability
characteristics in both women and men.
MATERIALS AND METHODS
Study design
Clinical and genetic data were obtained as part of the longitu-
dinal SardiNIA Project (https://sardinia.irp.nia.nih.gov/), sup-
ported by the National Institute on Aging (NIA), started in 2001.
The cohort underwent a study visit every 3–4 years. Analysis for
this study was based on the fourth visit of 3688 participants that
completed evaluations for PKV by ultrasound, laboratory testing
and an administered survey and lacked renal cysts that would
bias PKV calculations. A subset of 2421 ‘healthy’ individuals was
used to define reference levels for PKV. The healthy subset was
defined by the absence of diabetes, obesity, metabolic syndrome,
hypertension, protein:creatinine ratio (PCR)>150mg/g or a his-
tory of cardiovascular (CV) disease.
The study was approved by the ethics committee and written
consent was obtained from all the participants.
Among 4531 individuals (57.1% female), 559 (49% female)
were excluded from analyses of kidney size because they had
cysts or polycystic kidney disease.
Kidney parenchymal measures
Ultrasound examination was used to determine kidney
length and PKV. A medical sonographer used the convex array
probe C5-2MHz of the Philips Healthcare ATL HDI 3500 ul-
trasound device. Ultrasound images for each kidney were col-
lected in the longitudinal and transverse planes, assessing
maximum length, anteroposterior diameter and width and
thickness of the parenchyma. Renal length was measured as the
maximum distance between the upper and lower pole in the
longitudinal plane at the median level. The anteroposterior di-
ameter and width were measured in the transverse plane per-
pendicular to the longitudinal axis of the kidney, in the hilum.
The anteroposterior diameter and the width were measured in or-
thogonal directions. Parenchymal thickness was measured in the
longitudinal scan as the distance between the renal capsule and the
border of the renal sinus fat separation. We considered the mean
of three consecutive measures. PKV was estimated using ellipsoid
volume equations [18] (see Supplementary data for details).
Clinical characteristics
Participants were interviewed to collect sociodemographic in-
formation, medical and family history, BW, lifestyle, health
behaviours (smoking, drinking, coffee intake etc.) and medica-
tions. Anthropometric measures (height, weight and waist
circumference) and resting blood pressure (BP) were determined.
Blood samples were collected by venipuncture after an overnight
fast of at least 12h at each visit. Blood tests included serum creati-
nine (SCr), uric acid, glucose, haemoglobin A1c and lipid levels.
SCr was measured with a kinetic alkaline picrate assay (Biosystem
A25) and calibrated to standardized values [1]. GFR was esti-
mated using the Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI) and full age spectrum (FAS) equations.
PCR was expressed as mg/g. Urine samples were centrifuged
(3000g for 10min) and the supernatant was then processed for
the pyrogallol red molybdate (PRM) dye-binding assay from
BioSystems (PROTEIN Urine 12501). The proteins in urine
reacted with PRM dye reagent to form a blue–purple colour com-
plex with maximum absorbance at 600nm and the tests were per-
formed using the A25 autoanalyser (BioSystems, Spain). Diabetes
was defined according to the guidelines of the American Diabetes
Association [19]. BP was measured using a calibrated desktop
sphygmomanometer after at least 5min of supine rest. Volunteers
were classified as hypertensive when BP was140mmHg systolic
or 90mmHg diastolic or when they reported taking antihyper-
tensive medication. Obesity was defined as body mass index
(BMI) 30kg/m2 (weight in kg divided by height in m2). Body
surface area (BSA) was calculated with the Dubois formula.
Metabolic syndrome was defined according to the International
Table 1. Demographic and clinical characteristics of 3972 individuals of
the SardiNIA study cohort
Characteristics Whole sample
(n ¼ 3972)
Healthy
(n ¼ 2256)
Age (years) 49.966 16.14 43.826 13.18
Age range (years)
20 52 (1.3) 42 (1.9)
20–39 1131 (28.5) 881 (39)
40–59 1693 (42.6) 1060 (47)
60–69 606 (15.3) 199 (8.8)
>70 490 (12.3) 74 (3.3)
Men 1657 (41.7) 847 (37.5)
Height (cm) 160.56 9.4 161.46 8.84
Waist:hip ratio 0.8956 0.083 0.8696 0.072
BMI (kg/m2) 25.636 4.58 23.66 3.05
BSA (m2) 1.686 0.20 1.656 0.17
eGFR (mL/min/1.73 m2) 104.336 17.78 110.56 14.02
SCr (mg/dL) 0.856 0.17 0.826 0.14
High SCr 100 (2.5) 0
PCR 150–<500 (mg/g) 74 (1.8) 26 (1.2)
PCR 500 (mg/g) 29 (0.8) 0
Small PKV 93 (2.3) 57 (2.5)
Large PKV 183 (4.6) 59 (2.6)
Diabetes 297 (7.5) 0
Hypertension 1119 (28.2) 0
Previous cardiac disease 232 (5.8) 0
Uric acid (mg/dL) 4.576 1.45 4.236 1.29
HDL cholesterol (mg/dL) 63.716 14.29 65.646 14.29
LDL cholesterol (mg/dL) 126.256 34.36 126.256 33.98
Triglycerides (mg/dL) 97.356 62.83 86.736 51.33
Smoker 745 (18.1) 509 (22.6)
Former smoker 956 (24.1) 453 (20.1)
Values are presented as mean6 SD or n (%). Healthy individuals are those without the
following comorbidities/risk factors: diabetes, obesity, hypertension, previous cardiac
disease, high SCr. Small and high PKVs are deﬁned as, respectively, <2.5 and >97.5 per-
centiles for sex and age. High SCr is deﬁned as >97.5 percentile for sex and age. GFR is
estimated with the CKD-EPI equation.
HDL, high-density lipoprotein; LDL, low-density lipoprotein.
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Diabetes Federation guidelines [20]. Cigarette smoking was
assessed as never, current or former at the time of the clinic visit;
individuals who smoke 1 cigarette/day and those who have quit
smoking for 1 year were defined, respectively, as current or former
smokers. Previous CV events, including coronary heart disease,
heart attack, heart failure and stroke, were self-reported.
Low and high BWwere defined as<2.5 and>4.5 kg, respec-
tively. Age, sex and BSA-adjusted heritability were assessed for
PKV using the POLY software program (freely available with
source code from http://csg.sph.umich.edu//chen/public/soft
ware/poly/Download.htm).
Statistical analysis
The distributions of clinical characteristics in the overall sam-
ple and the health subset were described. All regression analysis
used generalized estimating equations to account for the familial
relationships of the sample. Quantile regression was used to de-
termine how PKV changes with age in both men and women
with the 2.5 percentile, median and 97.5 percentile reported.
Multivariable logistic regression models were fit to identify the
clinical characteristics that independently associated with abnor-
mally large kidneys (>97.5 percentile for age and sex) and the
clinical characteristics that associated with abnormally small kid-
neys (>97.5 percentile for age and sex) in the whole sample.
Statistical analyses used R (http://www.r-project.org/). A sig-
nificance level of 0.05 was used.
RESULTS
Population sample
The SardiNIA project includes 6921 individuals, represent-
ing >60% of the adult population of 4 villages in the Lanusei
valley in Sardinia. All individuals included in the study were of
Sardinian origin and participate in a longitudinal study of age-
related quantitative traits on the island. Detailed description of
the cohort have been published previously [1]. The main clini-
cal and demographic characteristics of the 3688 SardiNIA par-
ticipants studied here are described in Methods section and are
shown in the Table 1.
Kidney sizes
PKV varied in a nonlinear fashion according to age and sex.
It remained almost stable until the fourth decade in women and
then gradually declined, sharply after the seventh decade
(P< 0.001). In contrast, it increased in men from youth to the
fifth decade before a progressive decline, resulting in a parabolic
curve over time (P< 0.001) with a sharp decline after the sev-
enth decade (Figure 1).
The median PKV among 2256 healthy individuals was
266 cc (2.5–97.5 percentiles 173–389). As shown in Table 2,
men had larger PKVs than women (P< 0.01 for all age groups).
As a further notable sex difference, PKV increased gradually up
to age 45 years in men and then gradually declined, whereas
FIGURE 1: Age-related changes in PKV in a subset of 2255 healthy individuals of the SardiNIA study cohort [846 (37.5%) are men].
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PKVs in women was relatively stable up to the age of 40–
50 years, with a subsequent decline (Table 2). The results were
similar when PKVwas adjusted for BSA or height and for kidney
length (Supplementary data, Figures 1S and 2S). Those results
were more evident in the ‘comorbid’ group (data not shown).
Clinical characteristics and CKD risk factors associated
with small and large PKVs
Independent predictors of small PKV (defined as PKV <2.5
percentile for age and sex) were male sex, high BMI, low height,
low waist:hip ratio and high SCr (Table 3).
Independent statistically significant predictors of large PKV
(>97.5 percentile for age and sex in the healthy group) were fe-
male sex, diabetes, obesity, high height, high waist:hip ratio and
low SCr (Table 3). The results were similar when PKV was ad-
justed for BSA, but the anthropometric variables lost their sta-
tistical significance (Supplementary data, Table 1S).
In contrast to the strong effects of metabolic variables, ge-
netic heritability was modest (15% on PKV and 27% on kidney
length).
Kidney volume and renal function
BSA-adjusted PKV was directly related to GFR estimated
with either the CKD-EPI or FAS equation, and the association
was stronger in the >70-years-old group (Pearsons’s correla-
tion coefficient 0.32 and 0.35, respectively, with CKD-EPI and
FAS equations; Figure 2).
BW
When the cohort was split according to BW as low
(<2.5 kg), normal (2.5–4.5 kg) and high (>4.5 kg), we observed
that higher BW (>4.5 kg) was associated with larger kidney vol-
ume and lower BW (<2.5 kg) was associated with smaller kid-
ney volume. For BWs between 2.5 and 4.5 kg, intermediate
values of PKVwere observed (Figure 3).
DISCUSSION
Gender- and age-related changes in kidney size parameters
over the lifespan were clear in our cohort of 2431 healthy indi-
viduals. PKVs in males increased up to middle age and then
progressively declined, more sharply after 70 years of age,
whereas females trended towards a gradual kidney volume de-
crease through life. This tendency may be an early expression of
nephrosenescence and can reflect an ‘adaptive volume augmen-
tation’ in early adulthood, that is, a volume compensation for
some progressive loss of functional nephrons [3]. Consistent
with such a notion, measured GFR (mGFR) is stable or declines
slowly before a steeper decrease after the fourth decade [21, 22].
Since the human nephrogenesis is complete by 36weeks of
Table 2. The median (2.5–97.5 percentiles) PKV by sex and age group in a
subset of 2256 healthy individuals of the SardiNIA study cohort
Age group (years) PKV (cm3),
median (2.5–97.5 percentiles)
Male Female
Overall (n¼ 847–1409) 266.2 (173.5–389.1) 220.0 (137.3–331.9)
18–30 (n¼ 153–217) 249.7 (167.0–355.7) 225.0 (152.6–337.3)
30–40 (n¼ 231–321) 272.2 (176.5–372.3) 227.9 (148.7–346.6)
40–50 (n¼ 239–408) 276.6 (181.5–406.1) 231.7 (141.9–334.8)
50–60 (n¼ 134–279) 268.5 (179.3–385.3) 211.6 (138.1–313.1)
60–70 (n¼ 63–136) 260.2 (170.1–363.4) 200.6 (127.3–302.4)
70–80 (n¼ 23–41) 250.5 (174.6–372.8) 190.0 (122.5–322.5)
80–90 (n¼ 3–7) 207.0 (159.1–308.2) 164.5 (134.1–196.2)
Men had larger kidney PKVs than women (P < 0.01 for all age groups).
Table 3. Predictors of small and large kidney PKVs in a cohort of 3972 individuals of the SardiNIA study cohort
Small PKV Large PKV
Univariate Multivariate Univariate Multivariate
OR P-value OR P-value OR P-value OR P-value
Age (years) 1.006 0.5 – – 1.007 0.8 – –
Female 0.941 0.9 0.235 <0.001 0.517 0.5 2.035 0.01
Obesity 0.264 0.8 – – 7.106 0.18 4.368 <0.001
Diabetes 1.095 1.0 – – 2.892 0.4 1.723 0.03
Previous CV disease 2.363 0.7 – – 0.803 0.9 – –
High BP 0.768 0.9 – – 2.219 0.4 – –
Smoker 0.716 0.9 – – 1.285 0.8 – –
Former smoker 1.112 0.9 – – 1.603 0.6 – –
BMI, SD 0.394 <0.001 0.302 <0.001 2.171 0.03 – –
Height, SD 0.708 0.003 0.425 <0.001 1.621 <0.001 2.336 <0.001
Waist:hip ratio, SD 0.664 0.5 0.670 0.019 1.972 <0.001 1.766 <0.001
SCr, SD 1.391 0.5 1.853 <0.001 0.811 0.02 0.508 <0.001
PCR >500mg/g 0.00 1.0 – – 3.089 0.7 – –
HDL cholesterol, SD 1.288 0.02 – – 0.788 0.004 – –
LDL cholesterol, SD 0.803 0.07 – – 1.035 0.9 – –
Triglycerides, SD 0.770 0.06 – – 1.202 0.01 – –
Uric acid, SD 0.875 0.8 – – 1.250 0.05 – –
Family-based, logistic univariate and multivariate regression of low and large PKVs. Quantitative variables are scaled for continuous variables, ORs are expressed for each increase of 1
SD of the variable.
OR, odds ratio; SD, standard deviation.
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gestation [23], the initial increase in kidney volume in early
adulthood in men (Figure 1) cannot be due to increased neph-
ron numbers but most likely reflects nephron hypertrophy.
Consistent with this interpretation, adaptive hyperfiltration in
21 kidney donors [24] and in rats [25] after nephrectomy was
attributed to hypertrophy of the remaining nephrons [26].
During the lifespan, in fact, microdissected glomeruli from
autoptic normal kidneys increased in size up to 7-fold from in-
fancy to adulthood and then progressively shranked [25] with
nephrosclerosis and tubular atrophy [27]; and nephron
FIGURE 2: PKV and eGFR (estimated with the CKD-EPI and FAS equations) were directly related in all the age categories (P< 0.001). The
strength of the association was greater in patients >70 years [Pearson’s correlation r¼ 0.36 and 0.32, respectively, for FAS and CKD-EPI eGFR; 60–
70 years: r¼ 0.26 (FAS) and 0.20 (CKD-EPI); 40–60 years: r¼ 0.21 (FAS) and 0.17 (CKD-EPI); 20–40 years: r¼ 0.21 (FAS) and 0.18 (CKD-EPI)].
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hypertrophy has indeed been proposed as a compensation for
the progressive loss of more superficial glomeruli during neph-
rosclerosis in ageing [28–30]. A concomitant decrease in podo-
cyte density in hypertrophic glomeruli may further increase the
risk of glomerulosclerosis [31].
According to previous studies, cortical volume declines late
in life [7]: again, this could reflect increased sclerosis [32, 33]
and atubular glomeruli [34]. Nephrosclerosis and nephron hy-
pertrophy would thus have opposite effects on cortical volume
and the net effect can rationalize the biphasic curve we observed
during ageing: total PKV increases, followed after the fourth de-
cade by progressively increasing loss of total parenchymal and
cortical volume from nephrosclerosis and ischaemia. Thus
when we compared our PKV mean values (yellow) to those of
the kidney donors in Wang et al. [7] (blue) in females
(Figure 4A) and males (Figure 4B), the profiles were quite
similar.
Likewise, the trend of total kidney volume (TKV) mean val-
ues of the SardiNIA cohort (yellow) was similar to that in the
Framingham study (blue) for males (Figure 4C) and females
(Figure 4D) [35]. The mean values of Sardinians were consis-
tently lower (Supplementary data, Figures 3S and 4S)—likely
because of their smaller body size, because the means were al-
most the same when adjusted for BSA levels. The distribution
was wider in our cohort, reflecting greater population variability
or the different imaging techniques.
Sex differences
We found notable initial hypertrophy, especially in men.
A previous study of computed tomography (CT) scans of po-
tential kidney donors found somewhat similar results [7]: corti-
cal volumes showed age-related reduction in both men and
women, whereas medullary volume showed a slight, constant
increase in men but an initial increase followed by a subsequent
FIGURE 3: PKV by BW in a subset of 2057 individuals of the
SardiNIA study cohort.
FIGURE 4: Comparison between PKV in healthy (A) women and (B) men of the SardiNIA kidney cohort (solid line) and of living kidney
donors in Wang et al. [7] (dashed line). Comparison between TKV in healthy (C) women and (D) men of the SardiNIA kidney cohort (solid
line) and the Framingham study (Roseman et al. [35], dashed line). The thick lines are the median values, the thin lines the 2.5 and 97.5 per-
centiles. PKV and TKV are adjusted for body surface area (1.9 and 1.78 m2, respectively).
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decline in women (Figure 1). Physiological differences in the
kidneys in men and women may be driven by the kidney sex
hormone receptors [36, 37]. In a murine model of uninephrec-
tomy, glomerular volume of the remnant kidney increased
more in males than in females, dependent on testosterone stim-
ulus [38]. Androgens also increased kidney weight in rat mod-
els, may upregulate angiotensin II and are profibrotic,
stimulating mesangial extracellular matrix accumulation,
whereas oestrogens can suppress mesangial growth and extra-
cellular matrix accumulation [39].
Comorbidities
The whole sample and healthy sample had the same preva-
lence of small PKV, but large PKV was almost half as prevalent
in healthy individuals. (Pathologically small kidneys were not
detected, probably because individuals with advanced or end-
stage kidney disease were excluded from the analysis.)
Adjusted analyses showed diabetes and obesity as independent
predictors of large PKV. These comorbidities are associated with
hyperfiltration via overstimulation of the renin–angiotensin–al-
dosterone system (RAAS) [40], provoking intraglomerular hy-
pertension and adaptive functional augmentation. Thus diabetic
nephropathy and obesity are characterized by enlarged kidneys
with hyperfiltration and glomerulomegaly [41, 42]. The effect of
obesity was marked and the waist:hip ratio was further associated
with large PKV independent of BMI.
The effects of size and cormorbidities on kidney function are
hard to quantitate, but age correlates qualitatively with eGFR
(data not shown), and even more clearly with the reported ini-
tial stable or slowly declining level of mGFR followed by a
much faster decrease as age progresses [21, 22, 43]. Moreover,
eGFR correlates significantly with kidney volume, in all age cat-
egories, especially in the elderly.
BW and heritability
Our observational study is cross-sectional. Kidney measures
were obtained with ultrasound, which cannot differentiate be-
tween cortical and medullary parenchyma; moreover, kidney
volume was calculated with an ellipsoid formula. Furthermore,
because there is currently no acceptable way to determine neph-
ron number in living individuals, it is difficult to assess glomer-
ulus/nephron decline quantitatively. But as a crude index,
number correlates with BW: deceased neonates born small for
their gestational age have fewer nephrons than controls [23,
44]. Low-BW newborns have reduced ultrasonographic kidney
sizes in childhood [45], and we find that higher BW is associ-
ated with larger adult kidney volume and, we infer, correspond-
ingly greater or lower numbers of glomeruli in adult life, but
with no significant differences in eGFR. Overall, as suggested
earlier, low BW and reduced kidney size could thus be a surro-
gate for low nephron number [46]. Although PAX2 [47] and
OSR1 variation [48], for example, are associated with a reduc-
tion of newborn kidney size, there is less evidence for a substan-
tial effect of genetic factors on size measures in adults. Two
small studies [49, 50] estimated the heritability of renal length
as 45–50%. However, we found only modest heritability of
15% for PKV and 27% for kidney length in this large general
population cohort, which is especially well suited to assess heri-
tability accurately [51, 52]. Instead, the results underline—espe-
cially for volume—the strong environmental component in the
development of kidney size, including the effect of associated
nutritional factors that could respond to intervention.
Such factors likely account for the small kidney size associ-
ated with low BW, but it remains unclear whether those indi-
viduals show earlier or more advanced CKD or whether their
kidney size corresponds to their level of metabolic need, with
no increased risk of CKD.
CONCLUSIONS
In our general population cohort, ages 18–100 years, we character-
ized renal size in relation to ageing, gender, function and CKD risk
factors. Overall, a biphasic trend with age was observed in males
and, in a more pronounced way, in individuals with diabetes and
obesity.We suggest that the early increase could reflect an adaptive
volume augmentation, with hypertrophy responding to higher
metabolic needs, particularly in those with metabolic comorbid-
ities. Heritability was modest, whereas lifestyle effects were appar-
ent. In addition to high BW, obesity, high waist:hip ratio, height
and female sex were independent predictors of large PKV, whereas
SCr was an independent predictor of small kidneys. Further stud-
ies could assess whether resultant adult renal sizes determined
sonographically could represent a useful index of the level of adap-
tive volume augmentation and later nephrosenescence, especially
in the progressive CKD inmiddle age and thereafter.
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